Skip to main content
SpringerLink
Log in

Nerve Growth Factor Plays a Divergent Role in Mediating Growth of Rat C6 Glioma Cells via Binding to the P75 Neurotrophin Receptor

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Dysregulation of proliferation, differentiation and cell death play a major role in glial tumors, and there is evidence for regulatory mechanisms involving nerve growth factor (NGF) and its receptors in various CNS-derived tumor cell lines. The aim of our study was to observe the effect of exogenous recombinant NGF on C6 rat glioma growth, to characterize the role of endogenous NGF and the p75 neurotrophin receptor (p75) and to rule out whether p75 is necessary to mediate the effect of exogenous NGF. Recombinant exogenous NGF (1–100 ng/ml) was applied under different serum conditions (0%, 1%, 5%) and knockdown of endogenous NGF and p75 was achieved by lipid-mediated antisense oligonucleotide treatment. In presence of serum, NGF had a positive whereas in absence of serum NGF produced a negative effect on C6 cell number. A knockdown of NGF or p75 increased cell numbers and enhanced BrdU incorporation. In p75-knocked down cells NGF did not enhance C6 glioma growth in presence of serum. We conclude that (1) exogenous recombinant NGF enhances C6 glioma growth under serum conditions but decreases cell number in absence of serum, that (2) the effect of exogenous NGF is mediated by p75 alone or by heterodimers containing p75 and that (3) either basal levels of endogenous NGF or basal levels of p75 receptor moderate C6 glioma growth and represent an autoregulatory potential of C6 glioma cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Criscuolo GR: The genesis of peritumoral vasogenic brain edema and tumor cysts: a hypothetical role for tumor-derived vascular permeability factor. Yale J Biol Med 66: 277-314, 1993

    Google Scholar 

  2. Schlegel U, Moots PL, Rosenblum MK, Thaler HT, Furneaux HM: Expression of transforming growth factor alpha in human gliomas. Oncogene 5: 1839-1842, 1990

    Google Scholar 

  3. Stockhammer G, Manley GT, Johnson R, Rosenblum MK, Samid D, Lieberman F: Inhibition of proliferation and induction of differentiation in medulloblastoma-and astrocytoma-derived cell lines with phenylacetate. J Neurosurg 83: 672-681, 1995

    Google Scholar 

  4. Takahashi JA, Mori H, Fukumoto M, Igarashi K, Jaye M, Oda Y, Kikuchi H, Hatanaka M: Gene expression of fibroblast growth factors in human gliomas and meningeomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues. Proc Natl Acad Sci USA 87: 5710-5714, 1990

    Google Scholar 

  5. Maxwell M, Naber SP, Wolfe HL, Galanopoulos T, Hedley-Whyte ET, Black PM, Antoniades HN: Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance. J Clin Invest 86: 131-140, 1990

    Google Scholar 

  6. Wiesenhofer B, Weis C, Humpel C: Glial cell line-derived neurotrophic factor (GDNF) is a proliferation factor for rat C6 glioma cells: evidence from antisense experiments. Antisense Nucleic Acid Drug Dev 10: 311-321, 2000

    Google Scholar 

  7. Plate K, Breier G, Weich H, Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359: 845-848, 1992.

    Google Scholar 

  8. Aguado F, Ballabriga J, Pozas E, Ferrer I: TrkA immunoreactivity in reactive astrocytes in human neurodegenerative diseases and colchicine-treated rats. Acta Neuropathol 96: 495-501, 1998

    Google Scholar 

  9. Levine A, Broach J: Oncogenes and cell proliferation. Curr Opin Genet Dev 5: 1-4, 1995

    Google Scholar 

  10. Washiyama K, Muragaki Y, Rorke LB, Lee VM, Feinstein SC, Radeke MJ, Blumberg D, Kaplan DR, Trojanowski JQ: Neurotrophin and neurotrophin receptor proteins in medulloblastomas and other primitive neuroectodermal tumors of the pediatric central nervous system. Am J Pathol 148: 929-940, 1996

    Google Scholar 

  11. Wang Y, Hagel C, Hamel W, Muller S, Kluwe L, Westphal M: Trk A, B, and C are commonly expressed in human astrocytes and astrocytic gliomas but not by human oligodendrocytes and oligodendroglioma. Acta Neuropathol 96(4): 357-364, 1998

    Google Scholar 

  12. Yamakuni T, Ozawa F, Hishinuma F, Kuwano R, Takahashi Y, Amano T: Expression of beta-nerve growth factor mRNA in rat glioma cells and astrocytes from rat brain. FEBS Lett 223(1): 117-121, 1987

    Google Scholar 

  13. Emmett CJ, McNeeley PA, Johnson RM: Evaluation of human astrocytoma and glioblastoma cell lines for nerve growth factor release. Neurochem Int 30(4-5): 465-474, 1997

    Google Scholar 

  14. van Grunsven LA, Thomas A, Urdiales JL, Machenaud S, Choler P, Durand I, Rudkin BB: Nerve growth factorinduced accumulation of PC12 cells expressing cyclin D1: evidence for a G1 phase block. Oncogene 12(4): 855-862, 1996

    Google Scholar 

  15. Yaeger MJ, Koestner A, Marushige K, Marushige Y: The reverse transforming effects of nerve growth factor on five human neurogenic tumor cell lines: in vitro results. Acta Neuropathol 83(1): 72-80, 1991

    Google Scholar 

  16. Oelmann E, Sreter L, Schuller I, Serve H, Koenigsmann M, Wiedenmann B, Oberberg D, Reufi B, Thiel E, Berdel WE: Nerve growth factor stimulates clonal growth of human lung cancer cell lines and human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling. Cancer Res 55(10): 2212-2219, 1995

    Google Scholar 

  17. Singer HS, Hansen B, Martinie D, Karp CL: Mitogenesis in glioblastoma multiforme cell lines: a role for NGF and its TrkA receptors. J Neuro-Oncol 45(1): 1-8, 1999

    Google Scholar 

  18. Marushige Y, Raju NR, Marushige K, Koestner A: Modulation of growth and of morphological characteristics in glioma cells by nerve growth factor and glia maturation factor. Cancer Res 47(15): 4109-4115, 1987

    Google Scholar 

  19. Marushige Y, Marushige K, Koestner A: Growth inhibition of anaplastic glioma cells by nerve growth factor. Anticancer Res 12(6B): 2069-2073, 1992

    Google Scholar 

  20. Dobrowsky RT, Werner MH, Castellino AM, Chao MV, Hannun YA: Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science 265: 1596-1599, 1994

    Google Scholar 

  21. Kumar S, Huber J, Pena LA, Perez-Polo JR, Werrbach-Perez K, de Vellis J: Characterization of functional nerve growth factor-receptors in a CNS glial cell line: monoclonal antibody 217c recognizes the nerve growth factor-receptor on C6 glioma cells. J Neurosci Res 27(3): 408-417, 1990

    Google Scholar 

  22. Rodts GE Jr, Black KL: Trans retinoic acid inhibits in vivo tumour growth of C6 glioma in rats: effect negatively influenced by nerve growth factor. Neurol Res 16(3): 184-186, 1994

    Google Scholar 

  23. Watanabe T, Katayama Y, Kimura S, Yoshino A: Control of proliferation and survival of C6 glioma cells with modification of the nerve growth factor autocrine system. J Neuro-Oncol 41: 121-128, 1999

    Google Scholar 

  24. Althaus HH, Richter-Landsberg C: Glial cells as targets and producers of neurotrophins. Int Rev Cytol 197: 203-277, 2000

    Google Scholar 

  25. Kahn MA, Kumar S, Liebe D, Chang R, Parada LF, de Vellis J: Mice lackingNT-3, and its receptor TrkC, exhibit profound deficiencies in CNS glial cells. Glia 26: 153-165, 1999

    Google Scholar 

  26. Kofler P, Wiesenhofer B, Rehrl C, Baier G, Stockhammer G, Humpel C: Liposome-mediated gene transfer into established CNS cell lines, primary glial cells, and in vivo. Cell Transplant 7: 175-185, 1998

    Google Scholar 

  27. Wiesenhofer B, Humpel C: Improved lipid-mediated gene transfer into C6 glioma cells and primary glia using FuGene. J Neurosci Meth 92: 145-152, 1999

    Google Scholar 

  28. Whittemore SR, Friedman PL, Larhammar DG, Persson H, Gonzalez-Carvajal M, Holets VR: Rat beta-nerve growth factor sequence and site of synthesis in the adult hippocampus. J Neurosci Res 20: 403-410, 1988

    Google Scholar 

  29. Radeke MJ, Misko TP, Hsu C, Herzenberg LA, Shooter EM: Gene transfer and molecular cloning of the rat nerve growth factor receptor. Nature 325(605): 593-597, 1987

    Google Scholar 

  30. Levi-Montalcini R, Skaper SD, Dal Toso R, Petrelli L, Leon A: Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci 19(11): 514-520, 1996

    Google Scholar 

  31. Johnson D, Lanahan A, Buck CR, Sehgal A, Morgan C, Mercer E, Bothwell M, Chao M: Expression and structure of the human NGF receptor. Cell 47: 545-554, 1986

    Google Scholar 

  32. Rodriguez-Tébar A, Dechant G, Barde Y-A: Binding of brain-derived neurotrophic factor to the nerve growth factor receptor. Neuron 4: 487-492, 1990

    Google Scholar 

  33. Rodriguez-Tébar A, Dechant G, Götz R, Barde Y-A: Binding of neurotrophin-3 to its neuronal receptors and interactions with nerve growth factor and brain derived neurotrophic factor. EMBO J 11: 917-922, 1992

    Google Scholar 

  34. Ryden M, Murray Rust J, Glass D, Ilag LL, Trupp M, Yancopoulos GD, McDonald NQ, Ibanez CF: Functional analysis of mutant neurotrophins deficient in low-affinity binding reveals a role for p75LNGFR in NT-4 signalling. EMBO J 14: 1979-1990, 1995

    Google Scholar 

  35. Mahadeo D, Kaplan L, Chao MV, Hempstead BL: Highaffinity nerve growth factor binding displays a faster rate of association than p140trk binding: implications for multisubunit polypeptide receptors. J BiolChem 269: 6884-6891, 1994

    Google Scholar 

  36. Kaplan DR, Hempstead BL, Martin-Zanca D, Chao MV, Parada LF: The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science 252: 554-558, 1991

    Google Scholar 

  37. Yavin E, Gabai A, Gil S: Nerve growth factor mediates monosialoganglioside-induced release of fibronectin and J1/tenascin from C6 glioma cells. J Neurochem 56: 105-112, 1991

    Google Scholar 

  38. Kumar S, Weingarten DP, Callahan JW, Sachar K, de Vellis J: Regulation of mRNAs for three enzymes in the glial cell model C6 cell line. J Neurochem 43: 1455-1463, 1984

    Google Scholar 

  39. Hutton LA, de Vellis J, Perez-Polo JR: Expression of p75NGFR, trkA, and trkB mRNA in rat C6 glioma and type I astrocyte cultures. J Neurosci Res 32: 375-383, 1992

    Google Scholar 

  40. Kumar S, Pena LA, de Vellis J: CNS glial cells express neurotrophin receptors whose levels are regulated by NGF. Mol Brain Res 7: 163-168, 1993

    Google Scholar 

  41. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV: Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383: 716-719, 1996

    Google Scholar 

  42. Tornatore C, Rabin S, Baker-Cairns B, Keir S, Mocchetti I: Engraftment of C6-2B cells into the striatum of ACI nude rats as a tool for comparison of the in vitro and in vivo phenotype of a glioma cell line. Cell Transplant 6(3): 317-326, 1997

    Google Scholar 

  43. Raff MC, Miller RH: A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 303: 390-396, 1983

    Google Scholar 

  44. Leslie RA, Hunter AJ, Robertson HA: Antisense Technology in the Central Nervous System. Oxford University Press, New York, 1999, pp 1-7

    Google Scholar 

  45. Pilowsky PM, Suzuki S, Minson JB: Antisense oligonucleotides: a new tool in neuroscience. Clin Exp Pharmacol Physiol 21: 935-944, 1994

    Google Scholar 

  46. Stein CA: Antisense oligodeoxynucleotides-promises and pitfalls. Leukemia 6: 967-974, 1992

    Google Scholar 

  47. Suter-Crazzolara C, Unsicker K: GDNF mRNA levels are induced by FGF-2 in rat C6 glioblastoma cells. Mol Brain Res 41: 175-182, 1996

    Google Scholar 

  48. Cohen RI, Marmur R, Norton WT, Mehler MF, Kessler JA: Nerve growth factor and neurotrophin-3 differentially regulate the proliferation and survival of developing rat brain oligodendrocytes. J Neurosci 16: 6433-6442, 1996

    Google Scholar 

  49. McKinnon RD, Matsui T, Dubois-Dalcq M, Aaronson SA: FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 5: 603-614, 1990

    Google Scholar 

  50. Deloulme JC, Laeng P, Janet T, Sensenbrenner M, Baudier J: Expression of neuromodulin (GAP-43) and its regulation by basic fibroblast growth factor during the differentiation of O-2A progenitor cells. J Neurosci Res 36: 147-162, 1993

    Google Scholar 

  51. Mayer M, Bögler O, Noble M: The inhibition of oligodendrocytic differentiation of the O-2A progenitors caused by fibroblast growth factor is overridden by astrocytes. Glia 8: 12-19, 1993

    Google Scholar 

  52. Chittka A, Chao MV: Identification of a zinc finger protein whose subcellular distribution is regulated by serum and nerve growth factor. Proc Natl Acad Sci 96(19): 10 705-10 710, 1999

    Google Scholar 

  53. Bibel M, Barde Y-A: Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev 14(23): 2919-2937, 2000

    Google Scholar 

  54. Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y, Jakobson MD: Programmed cell death and the control of cell survival: lessons from the nervous system. Science 262: 695-700, 1993

    Google Scholar 

  55. Hale AJ, Smith CA, Sutherland LC, Stoneman VEA, Longthorne VL, Culhane AG, Williams GT: Apoptosis: Molecular regulation of cell death. Eur J Biochem 236: 1-26, 1996

    Google Scholar 

  56. Bamji SX, Majdan M, Pozniak CD, Belliveau DJ, Aloyz R, Kohn J, Causing C, Miller F: The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occuring sympathetic neuron death. J Cell Biol 140: 911-923, 1998

    Google Scholar 

  57. Yoon SO, Casaccia-Bonnefil P, Carter B, Chao MV: Competitive signaling between trkA and p75 nerve growth factor receptors determines cell survival. J Neurosci 18(9): 3273-3281, 1998

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Psychiatry, Clinic of Psychiatry, University Hospital Innsbruck, Innsbruck, Austria

    Carla Weis, Bettina Wiesenhofer & Christian Humpel

Authors
  1. Carla Weis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bettina Wiesenhofer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christian Humpel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weis, C., Wiesenhofer, B. & Humpel, C. Nerve Growth Factor Plays a Divergent Role in Mediating Growth of Rat C6 Glioma Cells via Binding to the P75 Neurotrophin Receptor. J Neurooncol 56, 59–67 (2002). https://doi.org/10.1023/A:1014410519935

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1014410519935

Search

Navigation